Machine Learning

National Vision's annual scholarship rewards optometry students exploring AI and telemedicine, revealing a strategic investment in the future of eye care.

Kiddie Academy's "STEM Adventures" offers free, hands-on science events nationwide, blending community outreach with a strategy to lead in early education.

A new campaign by Palvella Therapeutics and key partners aims to educate and empower patients with a rare disease, a strategic move ahead of a potential new drug.

Sabre appoints Niklas Andréen as CCO to accelerate airline adoption of its new AI-native tech, signaling a strategic pivot from development to execution.

In a strategic move to fortify national security, X-Bow is acquiring Evolution Space, boosting US rocket motor production and hypersonic capabilities.

Embodied AI firm XGSynBot unveils its Z1 wheeled robot, designed for factory floors, not labs, aiming to solve manufacturing's 'automation paradox'.

A new cybersecurity firm backed by industry veterans has raised $125M to unleash autonomous AI agents that reason and act at machine speed.

Quantum firm Zapata adds industry veterans to its board, signaling a strategic shift in the quantum race from hardware supremacy to software application.

Agenus activates a key manufacturing pact with Zydus, scaling production for its promising BOT+BAL cancer therapy ahead of regulatory filings and market launch.

A new drug targeting the root cause of deadly device infections enters a pivotal trial, offering hope to millions and challenging a $20 billion problem.

Extreme Connect 2026 showcases an AI-first strategy to challenge industry giants, promising a new era of automated, intelligent enterprise networks.

As Zepp Health unveils its 2025 performance, all eyes are on its fight for profitability and market share against giants like Garmin and Apple.

New report shows LinkedIn is the only platform with positive B2B ROAS, as the customer journey becomes a complex, seven-month marathon of self-education.

As D-Wave prepares for a major physics summit, its unique dual-platform strategy and new gate-model breakthroughs could challenge industry giants.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

Promising clinical trial results for Insulet's fully closed-loop system aim to revolutionize daily management for millions with Type 2 diabetes.

Paperpal's new HIPAA-ready AI platform for life sciences offers secure data handling, aiming to accelerate research while ensuring regulatory compliance.

Following a stock drop, SES AI launches a global tour to showcase its AI-driven battery tech, pivoting focus from EVs to energy storage and drones.

A new venture platform backed by industry veterans launches a hands-on incubator to solve key challenges for startups in the booming pet technology ecosystem.

Facing a labor crisis, Wilson James is deploying an AI platform to optimize operations and empower its workforce with flexible, transparent scheduling.